New VPAG scheme to save NHS £14 billion
The level of annual allowed growth in sales of branded medicines will double from two per cent per year in 2024 to four per...
ABPI proposes ‘Voluntary Scheme for Pricing, Access and Growth’ to support NHS and economic growth
The Association of the British Pharmaceutical Industry (ABPI) has proposed a Voluntary Scheme for Pricing, Access and Growth (VPAG) that aims to deliver a sustainable...